Advanced search
Publication Cover
Clinical Toxicology Volume 55, 2017 - Issue 5
Submit an article Journal homepage
1,327
Views
47
CrossRef citations to date
0
Altmetric
Clinical Research

Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015

Rachelle AbouchedidClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK;
,
Simon HudsonLaboratory and Managed Services, LGC Ltd, Fordham, Cambridgeshire, UK;
,
Natalie ThurtleClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; ORCID Iconhttp://orcid.org/0000-0001-6754-7340
ORCID Icon,
Takahiro YamamotoClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK;
,
James H. HoClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK;
,
George BaileyClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK;
,
Michelle WoodDepartment of Health Sciences, Waters Corporation, Wilmslow, Cheshire, UK;
,
Nele SadonesLaboratory of Toxicology, Ghent University, Ghent, Belgium;
,
Christophe P. StoveLaboratory of Toxicology, Ghent University, Ghent, Belgium; ORCID Iconhttp://orcid.org/0000-0001-7126-348X
ORCID Icon,
Alison DinesClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK;
,
John R. H. ArcherClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; ;Faculty of Life Sciences and Medicine, King's College London, London, UK
,
David M. WoodClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; ;Faculty of Life Sciences and Medicine, King's College London, London, UK
&
Paul I. DarganClinical Toxicology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; ;Faculty of Life Sciences and Medicine, King's College London, London, UKCorrespondence[email protected]
 show all
Pages 338-345 | Received 11 Oct 2016, Accepted 17 Jan 2017, Published online: 20 Feb 2017

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Ishita Virmani, Alberto Oteo, Michael Dunn, Daniel Vidler, Clair Roper, Jane Officer, Gareth Hardy, Paul I. Dargan, Michael Eddleston, Jamie G. Cooper, Simon L. Hill, Rebecca Macfarlane, Liza Keating, Mark Haden, Simon Hudson & Simon H. L. Thomas. (2023) Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis. Clinical Toxicology 61:1, pages 39-46.
Read now
Georgina Blanco, Dan Vidler, Clair Roper, David M. Wood, Paul I. Dargan, Liza Keating, Rebecca Macfarlane, Stevan Emmett, Graham Johnson, Michael Eddleston, Simon L. Hill & Simon H. L. Thomas. (2021) Acute toxicity from the synthetic cathinone N-ethylpentylone (ephylone) in the United Kingdom. Clinical Toxicology 59:12, pages 1270-1273.
Read now
Piotr Adamowicz. (2021) Blood concentrations of synthetic cannabinoids. Clinical Toxicology 59:3, pages 246-251.
Read now
Xander M. R. Van Wijk, Robert Goodnough & Jennifer M. Colby. (2019) Mass spectrometry in emergency toxicology: Current state and future applications. Critical Reviews in Clinical Laboratory Sciences 56:4, pages 225-238.
Read now
Annelies Cannaert, Marthe Vandeputte, Sarah M. R. Wille & Christophe P. Stove. (2019) Activity-based reporter assays for the screening of abused substances in biological matrices. Critical Reviews in Toxicology 49:2, pages 95-109.
Read now
Nicholas E. Webb, David M. Wood, Shaun L. Greene, Laura J. Hunter, John R. H. Archer, Alison M. Dines & Paul I. Dargan. (2019) Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act. Clinical Toxicology 57:1, pages 36-41.
Read now
Murat Yalçın, Nazlı Tunalı, Handan Yıldız, Ayşenur Oğuz & Bülent Kadri Gültekin. (2018) Sociodemographic and clinical characteristics of synthetic cannabinoid users in a large psychiatric emergency department in Turkey. Journal of Addictive Diseases 37:3-4, pages 259-267.
Read now
Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji, Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, Gesine Liebetrau & Volker Auwärter. (2018) Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical Toxicology 56:6, pages 404-411.
Read now

Articles from other publishers (39)

Marie H. Deventer, Mattias Persson, Caitlyn Norman, Huiling Liu, Matthew J. Connolly, Niamh Nic Daéid, Craig McKenzie, Henrik Gréen & Christophe P. Stove. (2023) In vitro cannabinoid activity profiling of generic ban‐evading brominated synthetic cannabinoid receptor agonists and their analogs. Drug Testing and Analysis.
Crossref
Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier & João Maurício Castaldelli-Maia. (2023) Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review. Brain Sciences 13:7, pages 990.
Crossref
Michela Peruch, Riccardo Addobbati, Martina Padovano, Matteo Scopetti, Monica Concato, Davide Radaelli & Stefano D’Errico. (2023) Identification of 5F-Cumyl-PINACA, a Synthetic Cannabinoid, in the Herbal Material Used for Recreational Purposes in the Province of Trieste: Public Health Implications. Current Pharmaceutical Biotechnology 24:6, pages 758-765.
Crossref
K S C De Baerdemaeker, A M Dines, S Hudson, L J Sund, M L Waters, L J Hunter, M S Blundell, J R H Archer, D M Wood & P I Dargan. (2023) Isotonitazene, a novel psychoactive substance opioid, detected in two cases following a local surge in opioid overdoses. QJM: An International Journal of Medicine 116:2, pages 115-119.
Crossref
Marie H. Deventer, Caitlyn Norman, Robert Reid, Craig McKenzie, Niamh Nic Daéid & Christophe P. Stove. (2023) In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs. Forensic Science International 343, pages 111565.
Crossref
Alice Seywright, Alexander F. D Irvine, Denise A McKeown, Fiona M Wylie & Hazel J Torrance. (2022) Synthetic Cannabinoid Receptor Agonists in Postmortem Casework in Scotland. Journal of Analytical Toxicology 46:9, pages 1066-1072.
Crossref
Sara Malaca, Francesco P. Busardò, Giulio Nittari, Ascanio Sirignano & Giovanna Ricci. (2022) Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights. Current Pharmaceutical Design 28:32, pages 2603-2617.
Crossref
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, Fabiano Reniero, Claude Guillou & Christophe P. Stove. (2022) Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists. Drug Testing and Analysis 14:9, pages 1565-1575.
Crossref
Xinze Liu, Wei Liu, Ping Xiang, Taijun Hang, Yan Shi, Linna Yue & Hui Yan. (2022) Metabolism of ADB-4en-PINACA in Zebrafish and Rat Liver Microsomes Determined by Liquid Chromatography–High Resolution Mass Spectrometry. Journal of Analytical Chemistry 77:8, pages 1036-1046.
Crossref
Liesl K Janssens, Dimitri Boeckaerts, Simon Hudson, Daria Morozova, Annelies Cannaert, David M Wood, Caitlin Wolfe, Bernard De Baets, Michiel Stock, Paul I Dargan & Christophe P Stove. (2022) Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples. Clinical Chemistry 68:7, pages 906-916.
Crossref
Sam Craft, Michael Dunn, Dan Vidler, Jane Officer, Ian S. Blagbrough, Christopher R. Pudney, Graeme Henderson, Ahmed Abouzeid, Paul I. Dargan, Michael Eddleston, Jamie Cooper, Simon L. Hill, Clair Roper, Tom P. Freeman & Simon H. L. Thomas. (2022) Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. Addiction.
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 131 156 .
Christopher Yates & Piotr M. Kabata. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 181 202 .
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 451 536 .
Anaam Ameen, Kelly Brown & Lynn Dennany. (2021) Electrochemical Strategies for the Screening of Synthetic Cannabinoid BB-22 (QUCHIC) within a Toxicological Specimen. Journal of The Electrochemical Society 168:12, pages 126510.
Crossref
Adam Ametovski, Elizabeth A. Cairns, Katharina Elisabeth Grafinger, Annelies Cannaert, Marie H. Deventer, Shuli Chen, Xinyi Wu, Caitlin E. Shepperson, Felcia Lai, Ross Ellison, Roy Gerona, Karen Blakey, Richard Kevin, Iain S. McGregor, David E. Hibbs, Michelle Glass, Christophe Stove, Volker Auwärter & Samuel D. Banister. (2021) NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?. ACS Chemical Neuroscience 12:21, pages 4020-4036.
Crossref
Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, Eric Sparkes, Elizabeth Cairns, Samuel D. Banister, Volker Auwärter & Christophe P. Stove. (2021) Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB 1 receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay . Drug Testing and Analysis 13:7, pages 1402-1411.
Crossref
Marcin Zawadzki, Agnieszka Chłopaś-Konowałek, Karolina Nowak, Olga Wachełko & Paweł Szpot. (2020) Quantification of 5F-CUMYL-P7AICA in blood and urine from an authentic fatality associated with its consumption by UHPLC–MS/MS. Forensic Toxicology 39:1, pages 240-247.
Crossref
Andrea Piccioni, Sara Cicchinelli, Luisa Saviano, Emanuele Gilardi, Christian Zanza, Mattia Brigida, Gianluca Tullo, Gianpietro Volonnino, Marcello Covino, Francesco Franceschi & Raffaele La Russa. (2020) Risk Management in First Aid for Acute Drug Intoxication. International Journal of Environmental Research and Public Health 17:21, pages 8021.
Crossref
Liesl Janssens, Annelies Cannaert, Matthew J. Connolly, Huiling Liu & Christophe P. Stove. (2020) In vitro activity profiling of Cumyl‐PEGACLONE variants at the CB 1 receptor: Fluorination versus isomer exploration . Drug Testing and Analysis 12:9, pages 1336-1343.
Crossref
Anna Pinson, Azure L. Yarbrough, John M. Bush, Christian V. Cabanlong, Amal Shoeib, Bailey K. Jackson, Saki Fukuda, Jyoti Gogoi, William E. Fantegrossi, Keith McCain, Paul L. Prather, Ryoichi Fujiwara & Anna Radominska-Pandya. (2020) Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity. Pharmacology Biochemistry and Behavior 195, pages 172949.
Crossref
Elise Wouters, Jolien Walraed, Samuel D. Banister & Christophe P. Stove. (2019) Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists. Biochemical Pharmacology 169, pages 113623.
Crossref
Elise Wouters, Lukas Mogler, Annelies Cannaert, Volker Auwärter & Christophe Stove. (2019) Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐ tert ‐leucine . Drug Testing and Analysis 11:8, pages 1183-1191.
Crossref
Richard C. Kevin, Lyndsey Anderson, Iain S. McGregor, Rochelle Boyd, Jamie J. Manning, Michelle Glass, Mark Connor & Samuel D. Banister. (2019) CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist. Frontiers in Pharmacology 10.
Crossref
Carolina Noble, Annelies Cannaert, Kristian Linnet & Christophe P. Stove. (2018) Application of an activity‐based receptor bioassay to investigate the in vitro activity of selected indole‐ and indazole‐3‐carboxamide‐based synthetic cannabinoids at CB1 and CB2 receptors. Drug Testing and Analysis 11:3, pages 501-511.
Crossref
Annelies Cannaert, Marthe Vandeputte, Simon Hudson, David M Wood, Paul I Dargan & Christophe P Stove. (2019) Validation of Activity-Based Screening for Synthetic Cannabinoid Receptor Agonists in a Large Set of Serum Samples. Clinical Chemistry 65:2, pages 347-349.
Crossref
Laura Mercolini. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing 247 258 .
Jordan Yardain Amar, Jeffrey Ruta, David Rahimian, Rachel Leah Dillinger & Paul Katz. (2018) Toxic leukoencephalopathy with extrapyramidal dysfunction due to synthetic cannabinoids. Journal of Clinical Neuroscience 58, pages 213-214.
Crossref
Melissa Hobbs, Nicola J Kalk, Paul D Morrison & James M Stone. (2018) Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review. European Neuropsychopharmacology 28:12, pages 1289-1304.
Crossref
Luke De La Rue, David M. Wood & Paul I. Dargan. 2018. Handbook of Novel Psychoactive Substances. Handbook of Novel Psychoactive Substances 114 131 .
Samuel K. Cordeiro, Ryan C. Daro, Hyunuk Seung, Wendy Klein-Schwartz & Hong K. Kim. (2018) Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015. Addiction 113:10, pages 1850-1861.
Crossref
Jeremy Carlier, Xingxing Diao & Marilyn A. Huestis. (2018) Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection. Journal of Pharmaceutical and Biomedical Analysis 157, pages 27-35.
Crossref
Stefania Bonaccorso, Antonio Metastasio, Angelo Ricciardi, Neil Stewart, Leila Jamal, Naasir-Ud-Dinn Rujully, Christos Theleritis, Stefano Ferracuti, Giuseppe Ducci & Fabrizio Schifano. (2018) Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues. Brain Sciences 8:7, pages 133.
Crossref
Huiqiong Deng, Satyajit Mohite, Robert Suchting, David A. Nielsen & Olaoluwa O. Okusaga. (2018) Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders. Psychiatry Research 261, pages 248-252.
Crossref
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances 475 494 .
Sandra N. Staeheli, Michael Poetzsch, Veronica P. Veloso, Michael Bovens, Christian Bissig, Andrea E. Steuer & Thomas Kraemer. (2018) In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA . Drug Testing and Analysis 10:1, pages 148-157.
Crossref
Michael Bovens, Christian Bissig, Sandra N. Staeheli, Michael Poetzsch, Bernhard Pfeiffer & Thomas Kraemer. (2017) Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA. Forensic Science International 281, pages 98-105.
Crossref
Mitchell Longworth, Samuel D. Banister, Rochelle Boyd, Richard C. Kevin, Mark Connor, Iain S. McGregor & Michael Kassiou. (2017) Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues. ACS Chemical Neuroscience 8:10, pages 2159-2167.
Crossref
Annelies Cannaert, Florian Franz, Volker Auwärter & Christophe P. Stove. (2017) Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System. Analytical Chemistry 89:17, pages 9527-9536.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.